Current evidence and future of automated erythrocyte exchange in the treatment of severe malaria

Wiener Klinische Wochenschrift

Volumn 124, Issue 3 SUPPL., 2012, Pages 23-26

  Auer Hackenberg, Lorenz ^a   Winkler, Stefan ^a   Graninger, Wolfgang ^a   Worel, Nina ^a   Ramharter, Michael ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Automated red blood cell exchange; Erythrocytapheresis; Erythrocyte transfusion; Plasmodium falciparum; Severe malaria

Indexed keywords

ARTICLE; AUTOMATED ERYTHROCYTE EXCHANGE; BRAIN MALARIA; DISEASE SEVERITY; ERYTHROCYTE; EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; MALARIA; MALARIA CONTROL; PARASITEMIA; PERIPHERAL CIRCULATION; RESPIRATORY DISTRESS; SURVIVAL; ERYTHROCYTE TRANSFUSION; REVIEW; RISK FACTOR; STATISTICS; TREATMENT OUTCOME;

ERYTHROCYTE TRANSFUSION; EVIDENCE-BASED MEDICINE; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; MALARIA; RISK FACTORS; TREATMENT OUTCOME;

EID: 84877659048     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-012-0238-6     Document Type: Article

References (34)

1. BMG. Jahresstatistik meldepflichtiger Infektionskrankheiten ab 2000. Bundesministerium für Gesundheit. 2011. http://bmg.gv.at/home/Schwerpunkte/ Krankheiten/Uebertragbare-Krankheiten/Statistiken/Jahresstatistik- meldepflichtiger-Infektionskrankheiten-ab-2000. Accessed 14 Jan 2012.
2. WHO. Guidelines for the treatment of malaria, second edition. World Health Organization. 2010. http://whqlibdoc.who.int/publications/2010/ 9789241547925-eng.pdf. Accessed 14 Jan 2012.
3. Robak O, Bojic A, Locker GJ, Laczika K, Ramharter M, Staudinger T. The use of drotrecogin alfa in severe falciparum malaria. Anaesth Intensive Care. 2010;38(4):751-4.
4. WHO. Severe falciparum malaria. World Health Organization, communicable diseases cluster. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):S1-90.
5. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989;321(2):65-70. (Pubitemid 19170393)
6. Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis. 2002;34(9):1192-8. (Pubitemid 34450666)
7. Mordmüller B, Kremsner PG. Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Clin Infect Dis. 1998;26(4):850-2.
8. Rouvier B, Maudan P, Debue JF, Joussemet M, Roué R. Traitement par érythrophérèse d'un accès pernicieux palustre. Ann Fr Anesth Reanim. 1988;7(3):257-60.
9. Vachon F, Wolff M, Clair B, Regnier B. Treatment of severe malaria by exchange transfusion. N Engl J Med. 1990;322(1):58-9. (Pubitemid 20023839)
10. Kernoff LM, Botha MC, Jacobs P. Exchange transfusion in sickle cell disease using a continuous-flow blood cell separator. Transfusion 1977;17(3):269-71. (Pubitemid 8155196)
11. Files JC, Case CJ, Morrison FS. Automated erythrocyte exchange in fulminant falciparum malaria. Ann Intern Med. 1984;100(3):396.
12. Sighinolfi L, Libanore M, Bicocchi R, Reverberi R, Bedetti A, Ghinelli F. Treatment of cerebral malaria by erythrocyte exchange. Recenti Prog Med. 1990;81(12):804-5.
13. Lercari G, Paganini G, Malfanti L, et al. Apheresis for severe malaria complicated by cerebral malaria, acute respiratory distress syndrome, acute renal failure, and disseminated intravascular coagulation. J Clin Apher. 1992;7(2):93-6.
14. Mainwaring CJ, Leach MJ, Nayak N, Green ST, Jones DA, Winfield DA. Automated exchange transfusion for life-threatening Plasmodium falciparum malaria-lessons relating to prophylaxis and treatment. J Infect. 1999;39(3):231-3. (Pubitemid 30099571)
15. Macallan DC, Pocock M, Bishop E, et al. Automated erythrocytapheresis in the treatment of severe falciparum malaria. J Infect. 1999;39(9):233-6. (Pubitemid 30099572)
16. Macallan DC, Pocock M, Robinson GT, Parker-Williams J, Bevan DH. Red cell exchange, erythrocytapheresis, in the treatment of malaria with high parasitaemia in returning travellers. Trans R Soc Trop Med Hyg. 2000;94(4):353-6. (Pubitemid 30662336)
17. Weir EG, King KE, Ness PM, Eshleman SH. Automated RBC exchange transfusion: treatment for cerebral malaria. Transfusion 2000;40(6):702-7. (Pubitemid 30413325)
18. Zhang Y, Telleria L, Vinetz JM, Yawn D, Rossmann S, Indrikovs AJ. Erythrocytapheresis for Plasmodium falciparum infection complicated by cerebral malaria and hyperparasitemia. J Clin Apher. 2001;16(1):15-8. (Pubitemid 32374498)
19. Deshpande A, Kalgutkar S, Udani S. Red cell exchange using cell separator (therapeutic erythrocytapheresis) in two children with acute severe malaria. J Assoc Physicians India. 2003;51:925-6. (Pubitemid 41279881)
20. Boctor FN. Red blood cell exchange transfusion as an adjunct treatment for severe pediatric falciparum malaria, using automated or manual procedures. Pediatrics 2005;116(4):592-5. (Pubitemid 44542802)
21. Nieuwenhuis JA, Meertens JH, Zijlstra JG, Ligtenberg JJ, Tulleken JE, Van Der Werf TS. Automated erythrocytapheresis in severe falciparum malaria: A critical appraisal. Acta Trop. 2006;98(3):201-6. (Pubitemid 44066282)
22. Balint B, Ostojic G, Pavlovic M, et al. Cytapheresis in the treatment of cell-affected blood disorders and abnormalities. Transfus Apher Sci. 2006;35(1):25-31. (Pubitemid 44354319)
23. Fernández-Fuertes LF, Tapia-Martín M, Angel-Moreno A, et al. Eritrocitaféresis automatizada en el tratamiento de la malaria grave: estudio de 6 pacientes. Med Clin (Barc). 2008;131(8):298-301.
24. Harris P, Price S, Senthuran S, Cochupanachimootil J, Norton R. Automated erythrocytapheresis for severe falciparum malaria. Intern Med J. 2011;41(1a):60-3.
25. Watanaboonyongcharoen P, Park YA, Poisson JL, Brecher ME. Rapid increases in parasitemia following red cell exchange for malaria. J Clin Apher. 2011;26(6):315-9.
26. Auer-Hackenberg L, Staudinger T, Bojic A, et al. Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study. Malar J. 2012;11(1):158
27. Lalloo DG, Shingadia D, Pasvol G, et al. UK malaria treatment guidelines. J Infect. 2007;54(2):111-21. (Pubitemid 46083312)
28. Szczepiorkowski ZM, Winters JL, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010;25(3):83-177.
29. Ramharter M, Kollaritsch H, Thalhammer F, et al. Consensus statement - Malaria Prävention, Diagnostik und Therapie. Ärztezeitung. 2011; Supplementum September 2011:1-12. http://www.oeginfekt.at/download/cs-malaria. pdf. Accessed 14 Jan 2012.
30. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA. 2007;297(20):2264-77. (Pubitemid 47018065)
31. DTG. Leitlinie: Diagnostik und Therapie der Malaria. Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit. 2011 (6 Sept):1-72. http://www.dtg.org/uploads/media/Leitlinien-Malaria-2011-01.pdf. Accessed 14 Jan 2012.
32. Bélard S, Kurth F, Winkler S, Graninger W, Ramharter M. Treatment of malaria in Austria: hazardous for patients or physicians? Wien Klin Wochenschr. 2009;121(17-18):598.
33. Dondorp A, Nosten F, Stepniewska K, et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366(9487):717-25. (Pubitemid 41207233)
34. Ramharter M, Oyakhirome S, Klein Klouwenberg P, et al. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis. 2005;40(12):1777-84. (Pubitemid 40799947)